Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.51 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 1/20 | 0.31 |
| ▸ | NPY4R | P50391 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.30 |
| ▸ | GNPAT | O15228 | 2/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
| ▸ | BMP1 | P13497 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL660692 | 0.92 | NOD1 (0.49) | NOD1GNPAT | |
| SCHEMBL1249331 | 0.92 | NOD1 (0.49) | NOD1GNPAT | |
| SCHEMBL7918137 | 0.85 | NOD1 (0.39) | NOD1SIRT5DPP8GNPATDPP4 | |
| SCHEMBL15541251 | 0.80 | BHMT (0.37) | NOD1ALDH1A1 | |
| SCHEMBL1373235 | 0.80 | ALDH1A1 (0.36) | DPP8DPP4DPP9ALDH1A1 | |
| SCHEMBL11103615 | 0.77 | NOD1 (0.59) | NOD1SIRT5ERAP2ERAP1LNPEP | |
| SCHEMBL4217551 | 0.77 | NOD1 (0.59) | NOD1SIRT5ERAP2ERAP1LNPEP | |
| SCHEMBL7927426 | 0.77 | NOD1 (0.59) | NOD1SIRT5ERAP2ERAP1LNPEP | |
| SCHEMBL27892995 | 0.77 | NOD1 (0.59) | NOD1SIRT5ERAP2ERAP1LNPEP | |
| SCHEMBL2467621 | 0.76 | BHMT (0.48) | NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9388400-B2 | Composition for use in mycobacteria diagnosis | LYSANDO AG (LI) | 2016-07-12 | — | — | US | claimed |
| US-20150344859-A1 | COMPOSITION FOR USE IN MYCOBACTERIA THERAPY | LYSANDO AG (LI) | 2015-12-03 | — | — | US | claimed |
| US-20150165013-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2015-06-18 | — | — | US | claimed |
| US-20150140572-A1 | COMPOSITION FOR USE IN MYCOBACTERIA DIAGNOSIS | LYSANDO AG (LI) | 2015-05-21 | — | — | US | claimed |
| EP-2679677-A1 | Composition for use in Mycobacteria therapy | Lysando Aktiengesellschaft (LI) | 2014-01-01 | — | — | EP | claimed |
| EP-2679232-A1 | Composition for use in Mycobacteria vaccination | Lysando Aktiengesellschaft (LI) | 2014-01-01 | — | — | EP | claimed |
| US-20170136102-A1 | PHAGE-DERIVED COMPOSITIONS FOR IMPROVED MYCOBACTERIAL THERAPY | BACTOCLEAR HOLDINGS PTE. LTD. (SG) | 2017-05-18 | — | — | US | disclosed |
| US-9388400-B2 | Composition for use in mycobacteria diagnosis | LYSANDO AG (LI) | 2016-07-12 | — | — | US | disclosed |
| US-20150344859-A1 | COMPOSITION FOR USE IN MYCOBACTERIA THERAPY | LYSANDO AG (LI) | 2015-12-03 | — | — | US | disclosed |
| US-20150165013-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2015-06-18 | — | — | US | disclosed |
| US-20150165013-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2015-06-18 | — | — | US | disclosed |
| US-20150140572-A1 | COMPOSITION FOR USE IN MYCOBACTERIA DIAGNOSIS | LYSANDO AG (LI) | 2015-05-21 | — | — | US | disclosed |
| WO-2014001570-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014001570-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014001571-A1 | COMPOSITION FOR USE IN MYCOBACTERIA DIAGNOSIS | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014001572-A1 | COMPOSITION FOR USE IN MYCOBACTERIA THERAPY | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | disclosed |
| EP-2679232-A1 | Composition for use in Mycobacteria vaccination | Lysando Aktiengesellschaft (LI) | 2014-01-01 | — | — | EP | disclosed |
| EP-2679677-A1 | Composition for use in Mycobacteria therapy | Lysando Aktiengesellschaft (LI) | 2014-01-01 | — | — | EP | disclosed |